Shareholder Information
Share management and Shareholder Meeting information
Q1 2024 Financial Results
April 25 2024 Download (529KB)Annual Report and Accounts 2023
March 13 2024 Download (15.6MB)FY 2023 Financial Results
February 22 2024 Download (628KB)Q3 2023 Financial Results
November 9 2023 Download (651KB)Q2/H1 2023 Financial Results
July 27 2023 Download (650KB)Indivior Announces Q1 2024 Financial Results
April 25 2024Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
March 11 2024Court Provides Final Approval of Settlement with Direct Purchaser Class in the Multidistrict Antitrust Litigation; Final Court Approval Concludes the Antitrust Multidistrict Litigation
February 29 2024Indivior Announces Q4 / FY 2023 Financial Results
February 22 2024Indivior Settles Patent Dispute with Teva Subsidiary Actavis
December 20 2023